Latest News in the pharma Industry

Research & Development

Novartis adds bispecific antibodies to its growing immuno-oncology portfolio through collaboration and licensing agreement with Xencor

Novartis adds bispecific antibodies to its growing immuno-oncology portfolio through collaboration and licensing agreement with Xencor

28 Jun 2016

Agreement is the latest in a series of acquisitions and strategic collaborations that have bolstered Novartis' deep and diverse immuno-oncology pipeline.

Read more 
New analysis of INPULSIS trials demonstrates efficacy of Ofev across a range of IPF patients using broader diagnostic criteria

New analysis of INPULSIS trials demonstrates efficacy of Ofev across a range of IPF patients using broader diagnostic criteria

27 Jun 2016

Ofev is effective in slowing disease progression in both diagnostic subgroups which confirms the efficacy of OFEV across a range of IPF patients.

Read more 
BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

27 Jun 2016

This milestone marks the sixth Breakthrough Therapy Designation for Opdivo.

Read more 
Manufactured stem cells to advance clinical research

Manufactured stem cells to advance clinical research

26 Jun 2016

Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.

Read more 
Allergan announces FDA approval of sNDA for Avycaz

Allergan announces FDA approval of sNDA for Avycaz

26 Jun 2016

Label now includes Phase III clinical data evaluating the safety and efficacy of Avycaz (in combination with metronidazole) in patients with complicated intra-abdominal infections.

Read more 
Cobra Biologics and Alligator Bioscience extend drug development partnership

Cobra Biologics and Alligator Bioscience extend drug development partnership

23 Jun 2016

Project will deliver second cell line for manufacture of immuno-oncology antibody ADC-1015 following ADC-1013 success.

Read more 
Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients

Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients

23 Jun 2016

A new analysis published in JAMA Cardiology is the first to quantify the possible impact of Entresto's potential benefit in reducing death.

Read more 
Leukemia has largest pipeline and most first-in-class innovation in hematological cancers space

Leukemia has largest pipeline and most first-in-class innovation in hematological cancers space

22 Jun 2016

Of the three major indications within hematological cancer, namely leukemia, lymphoma and myeloma, leukemia has the largest pipeline, with 798 products in active development.

Read more 
Takeda initiates world’s first norovirus vaccine field trial

Takeda initiates world’s first norovirus vaccine field trial

21 Jun 2016

Read more 
Scancell suspends trial of melanoma drug

Scancell suspends trial of melanoma drug

20 Jun 2016

Ongoing quality control analysis has revealed that the stored drug product is no longer within the original specification.

Read more 
PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

20 Jun 2016

Move approves the use of contract manufacturing organisations.

Read more 
Multi-centre trial to test new treatment for chronic cough

Multi-centre trial to test new treatment for chronic cough

20 Jun 2016

Trial to test the first new cough drug in 50 years.

Read more